Texas A&M University President Michael K. Young announced that Paul E. Ogden, M.D., has assumed the role of interim executive vice president and acting chief executive officer for Texas A&M Health Science Center effective June 1, 2015. In his current position, Dr. Ogden serves as interim dean for the Texas A&M College of Medicine and interim vice president for clinical affairs. He will continue to serve in this capacity while assuming his new leadership role.

 Ogden is a member of the Texas A&M College of Medicine charter class and received his degree with honors in 1981. After completing his internship in family medicine, followed by an internal medicine residency at the Mayo Graduate School, Ogden went on to complete a fellowship in Academic Internal Medicine at the University of North Carolina in Chapel Hill. He has served as a general internist and was involved with medical education at Scott & White Memorial Hospital in Temple for more than 24 years, where he held several academic roles including director of graduate medical education and vice-chair for academic affairs with the Texas A&M College of Medicine Department of Internal Medicine. During this time, Ogden honed national expertise in clinical curriculum and assessment, including simulation education. Ogden assumed a full-time leadership position at the Texas A&M Health Science Center College of Medicine in 2010, when he was named vice dean for academic affairs and brought to fruition a multi-year programmatic expansion to double student enrollment before being named interim dean in July 2013. He is board certified by the American Board of Internal Medicine, and is also a fellow of the American College of Physicians and a member of the American Medical Association and the Texas Medical Association.

 Ogden replaces Brett Giroir, M.D., who resigned from his position as executive vice president and chief executive officer of Texas A&M Health Science Center.  Giroir is an internationally renowned physician-scientist whose work has focused on life threatening infectious diseases. He assumed leadership of Texas A&M Health Science Center in October 2013.  Previously, Giroir served as vice chancellor for strategic initiatives at the Texas A&M University System and principal investigator for the Texas A&M Center for Innovation in Advanced Development and Manufacturing, a public-private partnership with the U.S. Department of Health and Human Services designed to enhance the nation’s emergency preparedness against emerging infectious diseases, including pandemic influenza, and chemical, biological, radiological and nuclear threats. From 2004 until 2008, Giroir served in the Federal Government as deputy director, then director, of the Defense Sciences Office of the Defense Advanced Research Projects Agency (DARPA). Giroir is the recipient of the Secretary of Defense Medal for Outstanding Public Service, and the Texas A&M University System Excellence in Innovation Award in 2010.

 “Over the past year, under the leadership of Dr. Giroir, the TAMHSC Executive Committee has put in place a comprehensive strategic plan, borne from our individual college aspirations and unifying us all in a common vision of Transforming Health,” Ogden said in a memo to Texas A&M Health Science Center faculty, staff, and students. “I look forward to working with each of you to advance those initiatives that are already underway and to continue building upon the strong foundation developed by our faculty, staff and students over the past several years. Thank you for your continued service to Texas A&M and the State of Texas.”

— Debbie Field